Candidatas a vacunas contra el coronavirus según fabricante y fase de investigación

(3 de noviembre de 2020)

Fase investigación

Fase

Sinovac

Wuhan Institute of Biological Products/Sinopharm

Beijing Institute of Biological Products/Sinopharm

University of Oxford/AstraZeneca

CanSino Biological Inc./Beijing Institute of Biotechnology

Gamaleya Research Institute

Janssen Pharmaceutical Companies

Novavax

Moderna/NIAID

BioNTech/Fosun Pharma/Pfizer

Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology, Chinese Academy of Sciences

Curevac

Institute of Medical Biology, Chinese Academy of Medical Sciences

Research Institute for Biological Safety Problems, Rep of Kazakhstan

Beijing Minhai Biotechnology Co., Ltd.

Inovio Pharmaceuticals/ International Vaccine Institute

Osaka University/ AnGes/ Takara Bio

Cadila Healthcare Limited

Genexine Consortium

Bharat Biotech

Kentucky Bioprocessing, Inc

Sanofi Pasteur/GSK

Israel Institute for Biological Research/Weizmann Inst. of Science

Arcturus/Duke-NUS

SpyBiotech/Serum Institute of India

Symvivo

ImmunityBio, Inc. & NantKwest Inc.

ReiThera/LEUKOCARE/Univercells

CanSino Biological Inc/Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China

Vaxart

Ludwig-Maximilians - University of Munich

Clover Biopharmaceuticals Inc./GSK/Dynavax

Vaxine Pty Ltd/Medytox

University of Queensland/CSL/Seqirus

Medigen Vaccine Biologics Corporation/NIAID/Dynavax

Instituto Finlay de Vacunas, Cuba

FBRI SRC VB VECTOR, Rospotrebnadzor, Koltsovo

West China Hospital, Sichuan University

University Hospital Tuebingen

COVAXX / United Biomedical Inc. Asia

Merck Sharp & Dohme/IAVI

Institute Pasteur/Themis/Univ. of Pittsburg CVR/Merck Sharp & Dohme

Beijing Wantai Biological Pharmacy/ Xiamen University

Imperial College London

People's Liberation Army (PLA) Academy of Military Sciences/Walvax Biotech.

Medicago Inc.

OMS